Hologic cuts annual revenue forecast on weak demand for breast health products
1. Hologic cuts fiscal 2025 revenue forecast due to declining breast health product sales. 2. Shares dropped 5% post-announcement, indicating negative market reaction.
1. Hologic cuts fiscal 2025 revenue forecast due to declining breast health product sales. 2. Shares dropped 5% post-announcement, indicating negative market reaction.
Lowered revenue forecast could reflect ongoing sales challenges, similar to past stock drops.
Revenue forecasts directly impact stock price; significant changes warrant attention.
Immediate market reaction was negative, impacting short-term stock performance.